Cardiogenic shock due to predominantly right ventricular failure complicating acute myocardial infarction.
暂无分享,去创建一个
C. Hassager | L. Holmvang | J. Møller | L. Jensen | H. Ravn | J. Josiassen | H. Schmidt | O. K. Helgestad | O. Helgestad
[1] G. Filippatos,et al. Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology , 2020, European journal of heart failure.
[2] H. Thiele,et al. Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock , 2020, Circulation. Cardiovascular interventions.
[3] C. Granger,et al. Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology , 2020, European heart journal. Acute cardiovascular care.
[4] C. Hassager,et al. Temporal trends in incidence and patient characteristics in cardiogenic shock following acute myocardial infarction from 2010 to 2017: a Danish cohort study , 2019, European journal of heart failure.
[5] C. Terkelsen,et al. Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. , 2019, American heart journal.
[6] Kristian Thygesen,et al. Fourth Universal Definition of Myocardial Infarction (2018). , 2018, Journal of the American College of Cardiology.
[7] T. Kawashima,et al. Clarifying the anatomy of the atrioventricular node artery. , 2018, International journal of cardiology.
[8] P. Parikh,et al. Gender Disparities in Presentation, Management, and Outcomes of Acute Myocardial Infarction , 2018, Current Cardiology Reports.
[9] B. Bozkurt,et al. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association , 2018, Circulation.
[10] H. Sørensen,et al. The Western Denmark Heart Registry: Its Influence on Cardiovascular Patient Care. , 2018, Journal of the American College of Cardiology.
[11] T. Friede,et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial , 2018, European heart journal.
[12] G. Chatellier,et al. Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes, 1997–2012 , 2017, European journal of heart failure.
[13] P. van der Harst,et al. Right Ventricular Function After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the Glycometabolic Intervention as Adjunct to Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction III Trial). , 2016, The American journal of cardiology.
[14] G. Filippatos,et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology , 2016, European journal of heart failure.
[15] Harlan M Krumholz,et al. Acute Myocardial Infarction in Women: A Scientific Statement From the American Heart Association , 2016, Circulation.
[16] D. McManus,et al. Decade-Long Trends (2001–2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction , 2016, Circulation. Cardiovascular quality and outcomes.
[17] Sigrun Alba Johannesdottir Schmidt,et al. The Danish National Patient Registry: a review of content, data quality, and research potential , 2015, Clinical epidemiology.
[18] G. Helft,et al. Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. , 2015, Archives of cardiovascular diseases.
[19] K. Denhaerynck,et al. Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction. , 2014, JAMA internal medicine.
[20] G. Schuler,et al. Gender differences in patients with cardiogenic shock complicating myocardial infarction: a substudy of the IABP-SHOCK II-trial , 2014, Clinical Research in Cardiology.
[21] W. Qiu,et al. Gender comparisons in cardiogenic shock during ST elevation myocardial infarction treated by primary percutaneous coronary intervention. , 2013, The American journal of cardiology.
[22] K. Fukuda,et al. The challenges in the management of right ventricular infarction , 2013, European heart journal. Acute cardiovascular care.
[23] Fred S Apple,et al. Third universal definition of myocardial infarction , 2012 .
[24] Thomas D. Scott,et al. Predictors of reperfusion delay in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention from the HORIZONS-AMI trial. , 2010, The American journal of cardiology.
[25] C. Catalano,et al. Right Ventricular Ischemic Injury in Patients With Acute ST-Segment Elevation Myocardial Infarction: Characterization With Cardiovascular Magnetic Resonance , 2010, Circulation.
[26] J. Tijssen,et al. Right ventricular dysfunction is an independent predictor for mortality in ST‐elevation myocardial infarction patients presenting with cardiogenic shock on admission , 2010, European journal of heart failure.
[27] J. Gore,et al. Thirty-Year Trends (1975 to 2005) in the Magnitude of, Management of, and Hospital Death Rates Associated With Cardiogenic Shock in Patients With Acute Myocardial Infarction: A Population-Based Perspective , 2009, Circulation.
[28] Adnan Kastrati,et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. , 2008, Journal of the American College of Cardiology.
[29] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[30] F. Van de Werf,et al. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial. , 2007, JAMA.
[31] B. Brodie,et al. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. , 2007, The American journal of cardiology.
[32] Elliott M. Antman,et al. Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction: Every Minute of Delay Counts , 2004, Circulation.
[33] M. Pfisterer. Right ventricular involvement in myocardial infarction and cardiogenic shock , 2003, The Lancet.
[34] J. Hochman,et al. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. , 2003, Circulation.
[35] J. Goldstein. Right versus left ventricular shock: a tale of two ventricles. , 2003, Journal of the American College of Cardiology.
[36] H. White,et al. Cardiogenic shock caused by right ventricular infarction: a report from the SHOCK registry. , 2003, Journal of the American College of Cardiology.
[37] H. White,et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. , 1999, The New England journal of medicine.
[38] W. O’Neill,et al. Rapid hemodynamic improvement after reperfusion during right ventricular infarction. , 1995, Journal of the American College of Cardiology.
[39] D. Hoffman,et al. Left-to-right ventricular interaction with a noncontracting right ventricle. , 1994, The Journal of thoracic and cardiovascular surgery.
[40] W P Santamore,et al. Comparative significance in systolic ventricular interaction. , 1991, Cardiovascular research.
[41] O. Nishiyama,et al. Right and left ventricular oxygen metabolism in open-chest dogs. , 1982, The American journal of physiology.